ATYR: aTyr Pharma Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for ATYR
Across the 10 sessions after earlier ATYR headlines, the stock closed higher 4 times and lower 6 times, with a median move of 7.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ATYR | SPY |
|---|---|---|---|
| Jul 15, 2026 | aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026 | +9.9% | +0.4% |
| May 15, 2026 | aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update | -10.0% | -1.2% |
| May 14, 2026 | aTyr Pharma to Participate in Upcoming Investor Conferences | +41.4% | +0.8% |
| May 12, 2026 | aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting | -44.2% | -0.2% |
| Mar 6, 2026 | aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update | -8.7% | -1.3% |
| Feb 23, 2026 | aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | -2.9% | -1.0% |
Keep researching ATYR
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- ATYR insider tradesEvery buy and sale reported by aTyr Pharma Inc. officers, directors and large holders.
- ATYR earnings historyPast aTyr Pharma Inc. earnings releases, newest first.
- ATYR financial statementsRevenue, profit, cash flow and balance sheet from aTyr Pharma Inc.'s SEC filings.
Quantisnow market dataNASDAQ
ATYR
aTyr Pharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2015
Get push alerts for ATYR
Full ATYR profile on Quantisnow Follow ATYR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time